(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

LUCIN LUPUS CLINICAL INVESTIGATORS NETWORK

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

LUCIN LUPUS CLINICAL INVESTIGATORS NETWORK

ST13

US500000088689280

Class

35, 42

Filing

88689280

Registration

7236729

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

62

Latest update

02/20/2026

Trademark type

Combined

Nice classes

35, 42

Filing date

11/12/2019

Registration date

12/05/2023

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

12/05/2023

Last transaction

02/20/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use

First use anywhere

2023-03-00

First use in commerce

2023-03-00

Drawing code

3

Owner type

03

Owner location

NEW YORK, NY, US

Examiner

ANKRAH, NAAKWAMA S

Law office

L90

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the stylized purple wording "LUCIN" with "U" in lower-case and "L", "C", "I", "N" in upper-case, appearing above a horizontal line that gradually changes color from purple to red. The stylized purple wording "LUPUS CLINICAL INVESTIGATORS NETWORK" appears below the horizontal line.

Holders and representatives

Holders

Lupus Research Alliance, Inc.
Lupus Research Alliance, Inc.

Representatives

Joyce M. Ferraro Fross Zelnick Lehrman & Zissu, P.C.

Technical classification

Nice Classes

Class 35Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 35

Medical personnel recruitmentrecruitment of scientists and physicians in the field of Lupus treatments and therapies

Class 42

Scientific research for medical purposes in the field of Lupus treatments and therapies

Publications

History of USPTO decisions and trademark events.

62 publications found

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

02/18/2026

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

02/18/2026

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

02/18/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

02/18/2026

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

02/18/2026

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

06/18/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/18/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

06/18/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

06/18/2024

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

04/24/2024

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

04/24/2024

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

04/24/2024

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

04/24/2024

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

04/24/2024

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

12/05/2023

R.PR

REGISTERED-PRINCIPAL REGISTER

12/05/2023

SUNA

NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

10/28/2023

CNPR

ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED

10/27/2023

SUPC

STATEMENT OF USE PROCESSING COMPLETE

09/18/2023

IUAF

USE AMENDMENT FILED

09/14/2023

EISU

TEAS STATEMENT OF USE RECEIVED

09/14/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/28/2023

EX5G

SOU EXTENSION 5 GRANTED

03/25/2023

AITU

CASE ASSIGNED TO INTENT TO USE PARALEGAL

03/25/2023

EXT5

SOU EXTENSION 5 FILED

03/15/2023

EEXT

SOU TEAS EXTENSION RECEIVED

03/15/2023

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/13/2022

EX4G

SOU EXTENSION 4 GRANTED

09/09/2022

EXT4

SOU EXTENSION 4 FILED

09/09/2022

EEXT

SOU TEAS EXTENSION RECEIVED

09/09/2022

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/15/2022

EX3G

SOU EXTENSION 3 GRANTED

03/11/2022

EXT3

SOU EXTENSION 3 FILED

03/11/2022

EEXT

SOU TEAS EXTENSION RECEIVED

03/11/2022

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

12/30/2021

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

12/30/2021

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

12/30/2021

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

12/30/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

09/09/2021

EX2G

SOU EXTENSION 2 GRANTED

09/07/2021

EXT2

SOU EXTENSION 2 FILED

09/07/2021

EEXT

SOU TEAS EXTENSION RECEIVED

09/07/2021

EXRA

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

03/16/2021

EX1G

SOU EXTENSION 1 GRANTED

03/12/2021

EXT1

SOU EXTENSION 1 FILED

03/12/2021

EEXT

SOU TEAS EXTENSION RECEIVED

03/12/2021

NOAM

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

09/15/2020

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

07/21/2020

PUBO

PUBLISHED FOR OPPOSITION

07/21/2020

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

07/01/2020

ALIE

ASSIGNED TO LIE

06/15/2020

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

06/12/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

06/11/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

06/11/2020

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

06/11/2020

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

12/17/2019

GNRT

NON-FINAL ACTION E-MAILED

12/17/2019

CNRT

NON-FINAL ACTION WRITTEN

12/17/2019

DOCK

ASSIGNED TO EXAMINER

12/13/2019

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

11/20/2019

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

11/19/2019

NWAP

NEW APPLICATION ENTERED

11/15/2019

Continuous trademark protection

Get notified about every new filing that threatens LUCIN LUPUS CLINICAL INVESTIGATORS NETWORK or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.